We are happy to announce our collaboration with The Ubellacker Lab from Harvard T.H. Chan School of Public Health. The Ubellacker Lab studies metabolic vulnerabilities in metastasizing cells to target and treat cancer, focusing on exploiting lipid metabolism to sensitize cancer cells to lipid oxidation as a novel therapeutic strategy to inhibit metastasis. Thanks to their support, we can study the lipid metabolism of cancerous breast cells.
If you are interested in reading more about their research, you can visit their webpage by visiting the following link: https://ubellackerlab.com/
